Sign in
CompletedPhase 4

IMPACT OF LEVOTHYROXINE ON ERECTILE FUNCTION IN PATIENTS WITH HYPOTHYROIDISM

Key facts

Who runs it
Asociacion Instituto De Investigacion Sanitaria Biobizkaia
Where
Spain1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 4
People taking part
90 people enrolled
Started
1 Oct 2024
Ended
1 Dec 2025
Type of study
Interventional
Record updated
23 December 2024

Who can take part

Age
18 years and older
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Heterosexual males over 18 years of age
  • Sexually active males
  • Males diagnosed with HTs (TSH >5 with normal T4)
  • Males with a diagnosis of ED according to the IIEF-15 questionnaire (score <25 points)
  • Ability to complete the IIEF-15, EHS, PGIC and EDITS questionnaires
  • Signature of informed consent

Who cannot take part

  • Patients with pelvic radiotherapy (external or brachytherapy)
  • Patients under active treatment for ED (phosphodiesterase 5 inhibitors, intraurethral or intracavernous alprostadil or with penile prosthesis placement)
  • Contraindication for taking treatment with levothyroxine or sildenafil
  • Presence of penile pathology that may explain the ED such as Peyronie's disease or hypospadias
  • Patients with diagnosed neurological disease (Parkinson's, multiple sclerosis, spinal cord trauma, etc)
  • Presence of endocrinological pathology that can explain the ED (analytical alteration of FSH, LH, progesterone, estradiol and/or testosterone hormones)
  • Patients operated on pelvic organs with possible neurological involvement (radical prostatectomy, abdomino-perineal amputation, etc.)
  • Patients with low sexual activity (<1 sexual encounter/15 days)
  • Patient unable to complete the questionnaires

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To assess the impact on sexual activity of levothyroxine treatment (adjusted for weight (kg) and baseline TSH values) in patients with subclinical hypothyroidism (TSH >5) and erectile dysfunction as measured by the International Index of Erectile Function (IIEF-5), Erectile hardness score (EHS), Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) and Patient Global Impression of Change (PGIC) questionnaires

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Impact of levothyroxine on erectile function measured by the IIEF-15, EHS, PGIC and EDITS questionnaires in patients with hypothyroidism. Prospective, randomized controlled clinical trial with sildenafil 100
Record updated
23 December 2024